The findings follow an analysis of data collected by a Canadian phone app that gathered feedback offered by 1,300 headache sufferers and nearly 700 migraine sufferers who used marijuana to treat their head pain.
In this Review, we provide an overview of the endocannabinoid system and the endocannabinoidome before discussing their involvement in and clinical relevance to a variety of neurological disorders, including Parkinson disease, Alzheimer disease, Huntington disease, multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, stroke, epilepsy and glioblastoma.
